Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Circulation. Cardiovascular Interventions|April 26, 2015
Reperfusion Times for Radial Versus Femoral Access in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Observations From the Cardiac Care Network Provincial Primary PCI RegistryWarren J Cantor, Dennis T Ko, Madhu K Natarajan, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 24, 2020
Very Early Changes in Quality of Life After Transcatheter Aortic Valve Replacement: Results From the 3M TAVR TrialSandra B Lauck, Suzanne V Arnold, Britt Borregaard, et al.JACC. Cardiovascular Interventions|May 26, 2012
Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findingsRodrigo Bagur, Josep Rodés-Cabau, Ronen Gurvitch, et al.Journal of the American College of Cardiology|September 29, 2018
Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL TrialSanjit S Jolly, John A Cairns, Shahar Lavi, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2022
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trialShamir R Mehta, Guillaume Pare, Eva M Lonn, et al.Circulation|March 23, 2005
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot TrialShamir R Mehta, Philippe Gabriel Steg, Christopher B Granger, et al.Circulation. Cardiovascular Interventions|July 29, 2021
Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment-Elevation Myocardial Infarction: Insights From the COMPLETE TrialPayam Dehghani, Warren J Cantor, Jia Wang, et al.Circulation. Cardiovascular Interventions|October 18, 2022
Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic StudyNeel M Butala, David A Wood, Haiyan Li, et al.Journal of the American College of Cardiology|November 6, 2025
Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized TrialShamir R Mehta, Natalia Pinilla-Echeverri, Denise Tiong, et al.American Heart Journal|October 23, 2023
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)Kevin R Bainey, David A Wood, Matthias Bossard, et al.Pageof 6